Clinical Practice Guidelines (CPG) on EBMonFHIR
0.8.0-snapshot - ci-build

Clinical Practice Guidelines (CPG) on EBMonFHIR - Local Development build (v0.8.0-snapshot) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

PlanDefinition: Dexamethasone Application (Experimental)

Official URL: https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/example/covid19-ventilated-patients-dexamethasone-application-plan Version: 4.0
Active as of 2021-12-12 Responsible: CPGonEBMonFHIR Computable Name: Dexamethasone_Application

Application of Dexamethasone: 6 mg once per day for 10 days p.o. or i.v. for ventilated COVID-19 patients

Generated Narrative: PlanDefinition

ResourcePlanDefinition "COVID19VentilatedPatientsDexamethasoneApplicationPlan"

Profile: Recommendation Plan

knowledgeCapability: computable

knowledgeRepresentationLevel: structured

partOf: Dexamethasone Application

Action Combination Method

url

method

value: Exactly (Action Combination Method#exactly)

url

threshold

value: 1

url: https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/example/covid19-ventilated-patients-dexamethasone-application-plan

version: 4.0

name: Dexamethasone_Application

title: Dexamethasone Application in ventilated COVID-19 patients

type: ECA Rule (PlanDefinitionType#eca-rule)

status: active

experimental: true

subject: Population_COVID19_Ventilated

date: 2021-12-12

publisher: CPGonEBMonFHIR

description: Application of Dexamethasone: 6 mg once per day for 10 days p.o. or i.v. for ventilated COVID-19 patients

action

code: Administration of substance (procedure) (SNOWMED CT#432102000)

definition: DexamethasoneApplicationActionOral

action

code: Administration of substance (procedure) (SNOWMED CT#432102000)

definition: DexamethasoneApplicationActionIntravenous